A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of systemically administered AZD4017,
compared with placebo, over a 28-day period in patients with raised intra-ocular pressure
(IOP).